Advanced Search
Search Results
6557 total results found
24 - 29.24 Opioid Receptor Agonists
29.24 Opioid Receptor Agonists randomized double-blind placebo-controlled trial. Addiction. 2005;100(4):489. Sasada K, Iwamoto K, Kawano N, et al. Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function ...
25 - 29.25 Opioid Receptor Antagonists Naltrexone,
29.25 Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone Strain EC, Moody DE, Stoller KB, Walsh SL, Bigelow GE. Relative bioavailability of different buprenorphine formulations under chronic dosing conditions. Drug Alcohol Depend. 2004;74:37. Sub...
26 - 29.26 Phosphodiesterase 5 Inhibitors
29.26 Phosphodiesterase-5 Inhibitors King A, De Wit H, Riley RC, Cao D, Niaura R. Efficacy of naltrexone in smoking cessation: A preliminary study and an examination of sex differences. Nicotine Tobacco Res. 2006;8(5):671. Krishnan-Sarin S, Rounsaville BJ, O’M...
27 - 29.27 Selective SerotoninNorepinephrine Reupt
29.27 Selective Serotonin–Norepinephrine Reuptake Inhibitors Assoc Nurses AIDS Care. 2013;24(1 Suppl):S135–S145. Tuncel A, Nalcacioglu V, Ener K, Aslan Y, Aydin O, Atan A. Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating...
28 - 29.28 Selective Serotonin Reuptake Inhibitors
29.28 Selective Serotonin Reuptake Inhibitors Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in t...
29 - 29.29 SerotoninDopamine Antagonists and Simil
29.29 Serotonin–Dopamine Antagonists and Similarly Acting Drugs (Second-Generation or Atypical Antipsychotics) Comprehensive Textbook of Psychiatry. 9th ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins; 2009:3190. Thase ME, Haight BR, Richard N, Rockett...
30 - 29.30 Stimulant Drugs and Atomoxetine
29.30 Stimulant Drugs and Atomoxetine Suzuki H, Gen K, Inoue Y. Comparison of the anti-dopamine D(2) and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereo...
31 - 29.31 Thyroid Hormones
29.31 Thyroid Hormones McElroy SL, Guerdjikova A, Kotwal R, Weige JA, Nelson EB. Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial. J Clin Psychiatry. 2007;68(3):390. Minzenberg MJ, Carter CS. Modafinil: A review of n...
32 - 29.32 Tricyclics and Tetracyclics
29.32 Tricyclics and Tetracyclics risk for postpartum depressive symptoms. Psychoneuroendocrinology. 2013;38(7):1007–1013. 29.32 Tricyclics and Tetracyclics The observation in 1957 that imipramine (Tofranil) had antidepressant effects led to the development of...
33 - 29.33 Valproate
29.33 Valproate Psychiatry. 1990;47:1093. Lai MW, Klein-Schwartz W, Rodgers GC, Abrams JY, Haber DA. 2005 Annual report of the American Association of Poison Control Centers’ national poisoning and exposure database. Clin Toxicol. 2006;44:803. Lapierre YD. A r...
34 - 29.34 Nutritional Supplements and Medical Foo
29.34 Nutritional Supplements and Medical Foods 29.34 Nutritional Supplements and Medical Foods Thousands of herbal and dietary supplements are being marketed today. Some are purported to have psychoactive properties. A number have even shown promise in the tr...
35 - 29.35 Weight Loss Drugs
29.35 Weight Loss Drugs REFERENCES Camp KM, Lloyd-Puryear MA, Huntington KL. Nutritional treatment for inborn errors of metabolism: Indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example. Mol Gen...
01 - 30.1 Electroconvulsive Therapy
30.1 Electroconvulsive Therapy Brain Stimulation Methods 30.1 Electroconvulsive Therapy Convulsive therapies for major psychiatric illnesses predate the modern therapeutic era, with the use of camphor reported as early as the 16th century and the existence of ...
02 - 30.2 Other Brain Stimulation Methods
30.2 Other Brain Stimulation Methods Psychiatry. 9th ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins; 2009:3285. Prudic J. Strategies to minimize cognitive side effects with ECT: Aspects of ECT technique. J ECT. 2008;24:46. Rapinesi C, Serata D, Casale...
03 - 30.3 Neurosurgical Treatments and Deep Brain
30.3 Neurosurgical Treatments and Deep Brain Stimulation Luber B, Kinnunen LH, Rakitin BC, Ellsasser R, Stern Y. Facilitation of performance in a working memory task with rTMS stimulation of the precuneus: Frequency- and time-dependent effects. Brain Res. 2007...
01 - 31.1 Introduction Infant, Child, and Adolesce
31.1 Introduction: Infant, Child, and Adolescent Development Child Psychiatry 31.1 Introduction: Infant, Child, and Adolescent Development The transactional nature of development in infancy, childhood, and adolescence, consisting of a continuous interplay betw...
02 - 31.2 Assessment, Examination, and Psychologic
31.2 Assessment, Examination, and Psychological Testing bullying. J Youth Adolesc. 2013;42:685–697. Briggs GG. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Philadelphia: Lippincott Williams & Wilkins; 2005. Brown GW, Ban M, C...
03 - 31.3 Intellectual Disability
31.3 Intellectual Disability sample. Appl Neuropsychol Child. 2013 [Epub ahead of print]. Kestenbaum CJ. The clinical interview of the child. In: Wiener JM, Dulcan MK, eds. The American Psychiatric Publishing Textbook of Child and Adolescent Psychiatry. 3rd ed...